These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 9704884

  • 1. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB.
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [Abstract] [Full Text] [Related]

  • 2. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes.
    Zhu SJ, Kavanaugh MP, Sonders MS, Amara SG, Zahniser NR.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1358-65. PubMed ID: 9316847
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
    Gorentla BK, Vaughan RA.
    Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
    [Abstract] [Full Text] [Related]

  • 4. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
    Chang MY, Lee SH, Kim JH, Lee KH, Kim YS, Son H, Lee YS.
    J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures.
    Guillet BA, Velly LJ, Canolle B, Masmejean FM, Nieoullon AL, Pisano P.
    Neurochem Int; 2005 Mar; 46(4):337-46. PubMed ID: 15707698
    [Abstract] [Full Text] [Related]

  • 6. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
    Lee FJ, Pristupa ZB, Ciliax BJ, Levey AI, Niznik HB.
    J Biol Chem; 1996 Aug 23; 271(34):20885-94. PubMed ID: 8702845
    [Abstract] [Full Text] [Related]

  • 7. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C, Vernier P, Sidhu A.
    Biochemistry; 2004 Feb 10; 43(5):1242-53. PubMed ID: 14756560
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
    Wiesinger JA, Buwen JP, Cifelli CJ, Unger EL, Jones BC, Beard JL.
    J Neurochem; 2007 Jan 10; 100(1):167-79. PubMed ID: 17227437
    [Abstract] [Full Text] [Related]

  • 9. Rapid regulation of the dopamine transporter: role in stimulant addiction?
    Zahniser NR, Sorkin A.
    Neuropharmacology; 2004 Jan 10; 47 Suppl 1():80-91. PubMed ID: 15464127
    [Abstract] [Full Text] [Related]

  • 10. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
    Wang W, Sonders MS, Ukairo OT, Scott H, Kloetzel MK, Surratt CK.
    Mol Pharmacol; 2003 Aug 10; 64(2):430-9. PubMed ID: 12869648
    [Abstract] [Full Text] [Related]

  • 11. The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscle cells: regulation by protein kinase A and protein kinase C.
    Ren J, Karpinski E, Benishin CG.
    J Pharmacol Exp Ther; 1996 Apr 10; 277(1):394-402. PubMed ID: 8613946
    [Abstract] [Full Text] [Related]

  • 12. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
    Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD.
    J Pharmacol Exp Ther; 1998 Nov 10; 287(2):744-51. PubMed ID: 9808705
    [Abstract] [Full Text] [Related]

  • 13. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.
    Sorkina T, Hoover BR, Zahniser NR, Sorkin A.
    Traffic; 2005 Feb 10; 6(2):157-70. PubMed ID: 15634215
    [Abstract] [Full Text] [Related]

  • 14. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
    Lee SH, Chang MY, Lee KH, Park BS, Lee YS, Chin HR, Lee YS.
    Mol Pharmacol; 2000 May 10; 57(5):883-9. PubMed ID: 10779370
    [Abstract] [Full Text] [Related]

  • 15. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function.
    Lee SH, Kang SS, Son H, Lee YS.
    Biochem Biophys Res Commun; 1998 May 19; 246(2):347-52. PubMed ID: 9610361
    [Abstract] [Full Text] [Related]

  • 16. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
    Pifl C, Wolf A, Rebernik P, Reither H, Berger ML.
    Neuropharmacology; 2009 Feb 19; 56(2):531-40. PubMed ID: 19000913
    [Abstract] [Full Text] [Related]

  • 17. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
    Jayanthi LD, Apparsundaram S, Malone MD, Ward E, Miller DM, Eppler M, Blakely RD.
    Mol Pharmacol; 1998 Oct 19; 54(4):601-9. PubMed ID: 9765501
    [Abstract] [Full Text] [Related]

  • 18. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
    Chen N, Trowbridge CG, Justice JB.
    J Pharmacol Exp Ther; 1999 Sep 19; 290(3):940-9. PubMed ID: 10454463
    [Abstract] [Full Text] [Related]

  • 19. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK.
    J Pharmacol Exp Ther; 2005 Aug 19; 314(2):575-83. PubMed ID: 15879005
    [Abstract] [Full Text] [Related]

  • 20. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
    Wilhelm CJ, Johnson RA, Lysko PG, Eshleman AJ, Janowsky A.
    J Pharmacol Exp Ther; 2004 Sep 19; 310(3):1142-51. PubMed ID: 15102929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.